참고문헌
- Beinfield, H. and Korngold, E. Chinese medicine and cancer care. Altern. Ther. Health Med. 9, 8-52, 2003
- Monti, D.A. and Yang, J. Complementary medicine in chronic cancer care. Semin. Oncol. 32, 225-231, 2005 https://doi.org/10.1053/j.seminoncol.2004.11.026
- Yoo, H.T., Noh, J.S. and Lim, Y.D. Hyangyak Jipsungbang, Haenglim Publishing Co., Seoul, p 717-718, 1977
- Wang, Y.S. Jungyi Yakli Yo Yngyong. People's Sanitation Publishing Co., Peking, p 709-710, 1983
- Choi, Y.H., Kim, E.Y., Park, K.Y., Rhee, S.H. and Lee, W.H. Antimutagenic effects of the juice and boiling water extract of Houttuynia cordata Thunb. J. Kor. Soc. Food Sci. Nutr. 23, 916-921, 1994
- Chung, C.K.,, Ham, S.S., Lee, S.Y., Oh, D.H., Choi, S.Y., Kang, I.J. and Nam, S.M., Effects of Houttuynia cordata ethanol extracts on serum lipies and antioxidant enzymes in rats fed high fat diet. J. Kor. Soc. Food Sci. Nutr. 28, 205-211, 1999
- Song, J.H., Kim, M.J., Kwon, H.D. and Park, I.H., Antimicrobial activity of fractional exyracts from Houttuynia cordata root. J. Kor. Soc. Food Sci. Nutr. 32, 1053-1058, 2003 https://doi.org/10.3746/jkfn.2003.32.7.1053
- Li, G.Z., Chai, O.H., Lee, M.S., Han, E.H., Kim, H.T. and Song, C.H. Inhibitory effects of Houttuynia cordata water extracts on anaphylactic reaction and mast cell activation. Biol. Pharm. Bull. 28, 1864-1868, 2005 https://doi.org/10.1248/bpb.28.1864
- Kim, H.J. Biological effects of Houttuynia cordata Thunb extract on murine and human immuno system. MS Thesis, Seoul National University, 2000
- Chun, E.Y. Partial purification of Houttuynia cordata Thunb extract and characterization of its immunological activities in human. MS Thesis, Seoul National University, 1997
- Kim, J., Ryu, H.S., Shin, J.H. and Kim, H.S. In vitro and ex vivo supplementation of Houttuynia cordata extract and immunomodulating effect in mice. J. Kor. Soc. Food Sci. Nutr. 34, 167-175, 2005 https://doi.org/10.3746/jkfn.2005.34.2.167
- Kim, S.K., Ryu, S.Y., No, J., Choi, S.U. and Kim, Y.S. Cytotoxic alkaloids from Houttuynia cordata. Arch. Pharm. Res. 24, 518-521, 2001 https://doi.org/10.1007/BF02975156
- Lee, S.T., Lee, Y.H., Choi, Y.J., Shon, G.M., Lee, H.J. and Heo, J.S. Composition of quercetin and soluble tanin in Houttuynia cordata Thunb according to growth stages and plant parts. Kor. J. Medicinal Corp Sci. 10, 12-16, 2002
- Toda, S. Antioxidative effects of polyphenols in leaves of Houttuynia cordata on protein fragmentation by copper-hydrogen peroxide in vitro. J. Med. Food. 8, 266-268, 2005 https://doi.org/10.1089/jmf.2005.8.266
- Jeong, H.W., Choi, J.H. and Jin, C.S. Effects of water extracts of Flos Lonicerae and herba on the proliferation of human cancer cell lines. Kor. J. Oriental Med. Pathol. 10, 126-132, 1996
- Bae, W.Y., Go, H.G. and Kim, C.H. Experimental study on the effects of heral acupuncture on the growth of melanoma B16 in mice. J. Kor. Acupuncture Moxibustion Soc. 18, 186-201, 2001
- Cha, J.Y., Jeon, B.S., Park, J.W., Moon, J.C. and Cho, Y.S. Effects of fermented compositions containing Inonotus obliquus and Houttuynia cordata on growth of human AGS gastric and HCT-15 colon cancer cells. J. Kor. Soc. Appl. Biol. Chem. 47, 202-207, 2004.
- Chang, J.S., Chiang, L.C., Chen, C.C., Liu, L.T., Wang, K.C. and Lin, C.C. Antileukemic activity of Bidens pilosa L. var. minor (Blume) Sherff and Houttuynia cordata Thunb. Am. J. Chin. Med. 29, 303-312, 2001 https://doi.org/10.1142/S0192415X01000320
- Choi, Y.H. Proteasome-mediated degradation of BRCA1 protein in MCF-7 human breast cancer cells. Int. J. Oncol. 19, 687-693, 2001
- Harper, J.W. Cyclin dependent kinase inhibitors. Cancer Surv. 29, 91-107, 1997
-
Datto, M.B., Yu, Y. and Wang, X.F. Functional analysis of the transforming growth factor
$\beta$ responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 270, 28623-28628, 1995 https://doi.org/10.1074/jbc.270.48.28623 - Zeng, Y.X. and El-Deiry, W.S. Regulation of p21WAF1/CIP1 expression by p53-independent pathways. Oncogene 12, 1557-1564, 1996
- Choi, Y.H., Lee, W.H., Park, K.Y. and Zhang L. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells. Jpn. J. Cancer Res. 91, 164-173, 2000 https://doi.org/10.1111/j.1349-7006.2000.tb00928.x
- Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R. and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704, 1993 https://doi.org/10.1038/366701a0
- Tchou, W.W., Rom, W.N. and Tchou-Wong, K.M. Novel form of p21 (WAF1/CIP1/SDI1) protein in phorbol ester-induced G2/M arrest. J. Biol. Chem. 271, 29556-29560, 1996 https://doi.org/10.1074/jbc.271.47.29556
- Dulic, V., Stein, G.H., Far, D.F. and Reed, S.I. Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol. Cell Biol. 18, 546-557, 1998 https://doi.org/10.1128/MCB.18.1.546
- Musgrove, E.A., Davison, E.A. and Ormandy, C.J. Role of the CDK Inhibitor p27 (Kip1) in mammary development and carcinogenesis: Insights from knockout mice. J. Mammary Gland Biol. Neoplasia 9, 55-66, 2004 https://doi.org/10.1023/B:JOMG.0000023588.55733.84
- Giercksky, K.E. COX-2 inhibition and prevention of cancer. Best Pract. Res. Clin. Gastroenterol. 15, 821-833, 2001 https://doi.org/10.1053/bega.2001.0237
- Thun, M.J., Henley, S.J. and Patrono, C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J. Natl. Cancer Inst. 94, 252-266, 2002 https://doi.org/10.1093/jnci/94.4.252
- Vainio, H. Is COX-2 inhibition a panacea for cancer prevention? Int. J. Cancer 94, 613-614, 2001 https://doi.org/10.1002/ijc.1518
- Dempke, W., Rie, C., Grothey, A. and Schmoll, H.J. Cyclooxygenase-2: a novel target for cancer chemotherapy? J. Cancer Res. Clin. Oncol. 127, 411-417, 2001 https://doi.org/10.1007/s004320000225
-
Surh, Y.J., Chun, K.S., Cha, H.H., Han, S.S., Keum, Y.S., Park, K.K. and Lee, S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-
$\kappa$ B activation. Mutat. Res. 480-481, 243-268, 2001 https://doi.org/10.1016/S0027-5107(01)00183-X - Sawaoka, H., Tsuji, S., Tsujii, M., Gunawan, E.S., Sasaki, Y., Kawano, S. and Hori, M. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab. Invest 79, 1469-1477, 1999
-
Yamamoto, Y. and Gaynor, R.B. Therapeutic potential of inhibition of the NF-
$\kappa$ B pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107, 135-142, 2001 https://doi.org/10.1172/JCI11914